Intuitive Surgical, Inc. (ISRG) Stake Increased by Shell Asset Management Co.

Shell Asset Management Co. boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,996 shares of the medical equipment provider’s stock after buying an additional 1,851 shares during the period. Shell Asset Management Co.’s holdings in Intuitive Surgical were worth $8,415,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of ISRG. Ipswich Investment Management Co. Inc. raised its stake in Intuitive Surgical by 13.0% in the first quarter. Ipswich Investment Management Co. Inc. now owns 390 shares of the medical equipment provider’s stock valued at $299,000 after buying an additional 45 shares during the last quarter. National Pension Service raised its stake in Intuitive Surgical by 2.9% in the first quarter. National Pension Service now owns 29,512 shares of the medical equipment provider’s stock valued at $22,614,000 after buying an additional 837 shares during the last quarter. Dynamic Advisors Solutions LLC raised its stake in Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock valued at $694,000 after buying an additional 5 shares during the last quarter. Gulf International Bank UK Ltd raised its stake in Intuitive Surgical by 2.1% in the first quarter. Gulf International Bank UK Ltd now owns 12,065 shares of the medical equipment provider’s stock valued at $9,247,000 after buying an additional 250 shares during the last quarter. Finally, Forte Capital LLC ADV raised its stake in Intuitive Surgical by 10.6% in the first quarter. Forte Capital LLC ADV now owns 2,562 shares of the medical equipment provider’s stock valued at $1,964,000 after buying an additional 245 shares during the last quarter. Hedge funds and other institutional investors own 97.56% of the company’s stock.

Intuitive Surgical, Inc. (ISRG) opened at 941.20 on Friday. The firm’s 50-day moving average is $937.40 and its 200-day moving average is $815.32. The company has a market cap of $34.97 billion, a price-to-earnings ratio of 45.08 and a beta of 0.39. Intuitive Surgical, Inc. has a 12 month low of $610.71 and a 12 month high of $974.66.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The business’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company posted $5.62 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post $23.86 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “[[title]]” was posted by [[site]] and is owned by of [[site]]. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at [[permalink]].

Several analysts have recently issued reports on the stock. Vetr lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $1,010.56 target price for the company. in a research note on Thursday, July 20th. Barclays PLC increased their price target on shares of Intuitive Surgical from $870.00 to $1,000.00 and gave the company an “overweight” rating in a research report on Friday, July 21st. They noted that the move was a valuation call. J P Morgan Chase & Co restated an “overweight” rating and set a $1,050.00 price target on shares of Intuitive Surgical in a research report on Friday, July 21st. Cantor Fitzgerald restated a “hold” rating and set a $1,050.00 price target on shares of Intuitive Surgical in a research report on Friday, July 21st. Finally, BidaskClub upgraded shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 23rd. Six equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $980.03.

In other Intuitive Surgical news, Director Michael A. Friedman sold 1,000 shares of the business’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $945.60, for a total transaction of $945,600.00. Following the completion of the sale, the director now directly owns 977 shares in the company, valued at approximately $923,851.20. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Salvatore Brogna sold 1,306 shares of the business’s stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $915.09, for a total value of $1,195,107.54. Following the sale, the executive vice president now owns 977 shares of the company’s stock, valued at $894,042.93. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,498 shares of company stock valued at $34,533,846. Corporate insiders own 2.50% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.